Literature DB >> 21835664

Down syndrome: national conference on patient registries, research databases, and biobanks.

Mary Lou Oster-Granite1, Melissa A Parisi, Leonard Abbeduto, Dorit S Berlin, Cathy Bodine, Dana Bynum, George Capone, Elaine Collier, Dan Hall, Lisa Kaeser, Petra Kaufmann, Jeffrey Krischer, Michelle Livingston, Linda L McCabe, Jill Pace, Karl Pfenninger, Sonja A Rasmussen, Roger H Reeves, Yaffa Rubinstein, Stephanie Sherman, Sharon F Terry, Michelle Sie Whitten, Stephen Williams, Edward R B McCabe, Yvonne T Maddox.   

Abstract

A December 2010 meeting, "Down Syndrome: National Conference on Patient Registries, Research Databases, and Biobanks," was jointly sponsored by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health (NIH) in Bethesda, MD, and the Global Down Syndrome Foundation (GDSF)/Linda Crnic Institute for Down Syndrome based in Denver, CO. Approximately 70 attendees and organizers from various advocacy groups, federal agencies (Centers for Disease Control and Prevention, and various NIH Institutes, Centers, and Offices), members of industry, clinicians, and researchers from various academic institutions were greeted by Drs. Yvonne Maddox, Deputy Director of NICHD, and Edward McCabe, Executive Director of the Linda Crnic Institute for Down Syndrome. They charged the participants to focus on the separate issues of contact registries, research databases, and biobanks through both podium presentations and breakout session discussions. Among the breakout groups for each of the major sessions, participants were asked to generate responses to questions posed by the organizers concerning these three research resources as they related to Down syndrome and then to report back to the group at large with a summary of their discussions. This report represents a synthesis of the discussions and suggested approaches formulated by the group as a whole.
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835664      PMCID: PMC3171614          DOI: 10.1016/j.ymgme.2011.07.005

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Clinical, social, and ethical implications of changing life expectancy in Down syndrome.

Authors:  A H Bittles; E J Glasson
Journal:  Dev Med Child Neurol       Date:  2004-04       Impact factor: 5.449

2.  Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006.

Authors:  Samantha E Parker; Cara T Mai; Mark A Canfield; Russel Rickard; Ying Wang; Robert E Meyer; Patrick Anderson; Craig A Mason; Julianne S Collins; Russell S Kirby; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-09-28

3.  Setting a public health research agenda for Down syndrome: summary of a meeting sponsored by the Centers for Disease Control and Prevention and the National Down Syndrome Society.

Authors:  Sonja A Rasmussen; Nedra Whitehead; Sarah A Collier; Jaime L Frías
Journal:  Am J Med Genet A       Date:  2008-12-01       Impact factor: 2.802

Review 4.  Down syndrome: issues to consider in a national registry, research database and biobank.

Authors:  Linda L McCabe; Edward R B McCabe
Journal:  Mol Genet Metab       Date:  2011-03-26       Impact factor: 4.797

5.  Racial disparities in median age at death of persons with Down syndrome--United States, 1968-1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-06-08       Impact factor: 17.586

6.  Screening for autism spectrum disorders in children with Down syndrome: population prevalence and screening test characteristics.

Authors:  Carolyn DiGuiseppi; Susan Hepburn; Jonathan M Davis; Deborah J Fidler; Sara Hartway; Nancy Raitano Lee; Lisa Miller; Margaret Ruttenber; Cordelia Robinson
Journal:  J Dev Behav Pediatr       Date:  2010-04       Impact factor: 2.225

7.  The changing survival profile of people with Down's syndrome: implications for genetic counselling.

Authors:  E J Glasson; S G Sullivan; R Hussain; B A Petterson; P D Montgomery; A H Bittles
Journal:  Clin Genet       Date:  2002-11       Impact factor: 4.438

8.  The four ages of Down syndrome.

Authors:  Alan H Bittles; Carol Bower; Rafat Hussain; Emma J Glasson
Journal:  Eur J Public Health       Date:  2006-07-19       Impact factor: 3.367

9.  Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB).

Authors:  Yaffa R Rubinstein; Stephen C Groft; Ronald Bartek; Kyle Brown; Ronald A Christensen; Elaine Collier; Amy Farber; Jennifer Farmer; John H Ferguson; Christopher B Forrest; Nicole C Lockhart; Kate R McCurdy; Helen Moore; Geraldine B Pollen; Rachel Richesson; Vanessa Rangel Miller; Sara Hull; Jim Vaught
Journal:  Contemp Clin Trials       Date:  2010-07-08       Impact factor: 2.226

10.  Causes of death and case fatality rates among infants with down syndrome in metropolitan Atlanta.

Authors:  Mikyong Shin; James E Kucik; Adolfo Correa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2007-11
View more
  14 in total

1.  Effects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study.

Authors:  Marcos Ricardo Datti Micheletto; Nelson Iguimar Valerio; Agnes Cristina Fett-Conte
Journal:  J Genet Couns       Date:  2013-06-23       Impact factor: 2.537

2.  Interindividual variability in the cardiac expression of anthracycline reductases in donors with and without Down syndrome.

Authors:  Adolfo Quiñones-Lombraña; Daniel Ferguson; Rachael Hageman Blair; James L Kalabus; Almedina Redzematovic; Javier G Blanco
Journal:  Pharm Res       Date:  2014-02-22       Impact factor: 4.200

Review 3.  Intellectual and developmental disabilities research centers: Fifty years of scientific accomplishments.

Authors:  Steven U Walkley; Leonard Abbeduto; Mark L Batshaw; Anita Bhattacharyya; Susan Y Bookheimer; Bradley T Christian; John N Constantino; Jean de Vellis; Daniel A Doherty; David L Nelson; Joseph Piven; Annapurna Poduri; Scott L Pomeroy; Rodney C Samaco; Huda Y Zoghbi; Michael J Guralnick
Journal:  Ann Neurol       Date:  2019-07-27       Impact factor: 10.422

4.  Analysis of Heteroplasmic Variants in the Cardiac Mitochondrial Genome of Individuals with Down Syndrome.

Authors:  Erik Hefti; Jonathan Bard; Javier G Blanco
Journal:  Hum Mutat       Date:  2016-09-26       Impact factor: 4.878

Review 5.  Pharmacotherapeutic Considerations for Individuals with Down Syndrome.

Authors:  Erik Hefti; Javier G Blanco
Journal:  Pharmacotherapy       Date:  2017-01-13       Impact factor: 4.705

6.  Obstructive sleep apnea in young infants with Down syndrome evaluated in a Down syndrome specialty clinic.

Authors:  Alida Goffinski; Maria A Stanley; Nicole Shepherd; Nichole Duvall; Sandra B Jenkinson; Charlene Davis; Marilyn J Bull; Randall J Roper
Journal:  Am J Med Genet A       Date:  2015-01-13       Impact factor: 2.802

7.  Comparative genome-wide DNA methylation analysis in myocardial tissue from donors with and without Down syndrome.

Authors:  Romina B Cejas; Jie Wang; Rachael Hageman-Blair; Song Liu; Javier G Blanco
Journal:  Gene       Date:  2020-08-27       Impact factor: 3.913

8.  Analysis of mtDNA, miR-155 and BACH1 expression in hearts from donors with and without Down syndrome.

Authors:  Erik Hefti; Adolfo Quiñones-Lombraña; Almedina Redzematovic; Jeffrey Hui; Javier G Blanco
Journal:  Mitochondrial DNA A DNA Mapp Seq Anal       Date:  2014-06-18       Impact factor: 1.514

9.  Auditory-Perceptual Features of Speech in Children and Adults With Down Syndrome: A Speech Profile Analysis.

Authors:  Raymond D Kent; Julie Eichhorn; Erin M Wilson; Youmi Suk; Daniel M Bolt; Houri K Vorperian
Journal:  J Speech Lang Hear Res       Date:  2021-03-31       Impact factor: 2.297

10.  β-Secretases, Alzheimer's Disease, and Down Syndrome.

Authors:  Robin L Webb; M Paul Murphy
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.